MedicarePartD.guide

A non-government resource built from CMS public data

LYUMJEV KWIKPEN 100 [iU]/mL Injection, Solution

Also known as Insulin Lispro-Aabc. Coverage in New York (CMS PDP Region 03).

1 of 10 stand-alone Part D plans in New York cover this drug on tier 3.

No plan applies a prior authorization, step therapy or quantity limit.

Every plan that covers it

Prior authorization
Step therapy
Quantity limit

Showing 1 of 1 plan

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
AARP Medicare Rx Preferred from UHC (PDP)$163.70/mo premium · $130.00 deductible3Preferred Brand15%15%$10.8195—None

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

Medicare Advantage plans

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D, and are sold county by county. Pick a county to see every Medicare Advantage drug plan there that covers this drug.

45 Medicare Advantage plans in NY do cover it

A patient on an MA-PD plan may have coverage even where no PDP lists the drug. NY: 45 plans.

See coverage in all 39 regions →